CXCR4 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: The second conclusion of this study was that CXCR4 antagonists could inhibit the activation of the signaling axis and could therefore restrain the invasiveness and tumorigenicity of GEM-R PaCa cells.